Patent Assignment
Reel/Frame 054915/0123
Assignment of Assignor's Interest
Recorded: 2021-01-14
Pages: 5
Assignor
SKOLNICK, PHIL
Executed: 2020-12-11
Assignee
OPIANT PHARMACEUTICALS, INC.
233 WILSHIRE BLVD., SUITE 280, SANTA MONICA, CALIFORNIA, 90401
Covered Property
(1)
Formulations and Methods for the Prevention of Opioid Overdose
Application:
17/055,647 →
Publication:
US 2021/0220346
Related Assignments
(5)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Jan 14, 2021
From: CRYSTAL, ROGER
To: OPIANT PHARMACEUTICALS, INC.
Reel/Frame 054915/0020 →
Assignment of Assignor's Interest
Jan 14, 2021
From: MAGGIO, EDWARD T.
To: AEGIS THERAPEUTICS LLC
Reel/Frame 054915/0209 →
Security Interest
Aug 6, 2021
From: NEURELIS, INC.; AEGIS THERAPEUTICS, LLC
To: ORBIMED ROYALTY & CREDIT OPPORTUNITIES III, LP
Reel/Frame 057111/0242 →
Merger
Jun 13, 2023
From: OPIANT PHARMACEUTICALS, INC.
To: INDIVIOR INC.
Reel/Frame 063931/0392 →
Release of Security Interest
Nov 14, 2024
From: ORBIMED ROYALTY & CREDIT OPPORTUNITIES III, LP
To: NEURELIS, INC.; AEGIS THERAPEUTICS, LLC
Reel/Frame 069359/0921 →